ArticleCold Spring Harbor molecular case studies2021

Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome.

Christopher A Ours et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.